These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23548335)

  • 1. New generation coronary stent technology--is the future biodegradable?
    Sammel AM; Chen D; Jepson N
    Heart Lung Circ; 2013 Jul; 22(7):495-506. PubMed ID: 23548335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary stents: looking forward.
    Garg S; Serruys PW
    J Am Coll Cardiol; 2010 Aug; 56(10 Suppl):S43-78. PubMed ID: 20797503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.
    Stefanini GG; Byrne RA; Serruys PW; de Waha A; Meier B; Massberg S; Jüni P; Schömig A; Windecker S; Kastrati A
    Eur Heart J; 2012 May; 33(10):1214-22. PubMed ID: 22447805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term patient benefit with biodegradable polymer biolimus eluting stent.
    Corti R
    Minerva Cardioangiol; 2012 Dec; 60(6):629-36. PubMed ID: 23147439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new wave in treatment of vascular occlusive disease: biodegradable stents--clinical experience and scientific principles.
    Brown DA; Lee EW; Loh CT; Kee ST
    J Vasc Interv Radiol; 2009 Mar; 20(3):315-24; quiz 325. PubMed ID: 19157901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Stent Materials and Coatings: A Technology and Performance Update.
    O'Brien B; Zafar H; Ibrahim A; Zafar J; Sharif F
    Ann Biomed Eng; 2016 Feb; 44(2):523-35. PubMed ID: 26139297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable stents and non-biodegradable stents.
    Garg S; Serruys P
    Minerva Cardioangiol; 2009 Oct; 57(5):537-65. PubMed ID: 19838147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully biodegradable coronary stents : progress to date.
    Ramcharitar S; Serruys PW
    Am J Cardiovasc Drugs; 2008; 8(5):305-14. PubMed ID: 18828642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of drug-eluting stents.
    Räber L; Windecker S
    Cardiovasc Ther; 2011 Jun; 29(3):176-89. PubMed ID: 20370793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioabsorbable and biocompatible stents. Is a new revolution coming?
    Rogacka R; Chieffo A; Latib A; Colombo A
    Minerva Cardioangiol; 2008 Oct; 56(5):483-91. PubMed ID: 18813184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No country for old stents? Improving long-term patient outcomes with biodegradable polymer drug-eluting stents.
    Byrne RA; Kastrati A
    Expert Rev Cardiovasc Ther; 2012 Apr; 10(4):429-32. PubMed ID: 22458576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering aspects of stents design and their translation into clinical practice.
    Sangiorgi G; Melzi G; Agostoni P; Cola C; Clementi F; Romitelli P; Virmani R; Colombo A
    Ann Ist Super Sanita; 2007; 43(1):89-100. PubMed ID: 17536159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Looking into the future with bioresorbable vascular scaffolds.
    Costopoulos C; Naganuma T; Latib A; Colombo A
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1407-16. PubMed ID: 24138526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of drug-eluting stents.
    Kukreja N; Onuma Y; Daemen J; Serruys PW
    Pharmacol Res; 2008 Mar; 57(3):171-80. PubMed ID: 18339557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Absorbable coronary stents. New promising technology].
    Erbel R; Böse D; Haude M; Kordish I; Churzidze S; Malyar N; Konorza T; Sack S
    Herz; 2007 Jun; 32(4):308-19. PubMed ID: 17607538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the abluminal biodegradable polymer stent to the polymer free stent. Clinical evidence.
    Navarese EP; Castriota F; Sangiorgi GM; Cremonesi A
    Minerva Cardioangiol; 2013 Apr; 61(2):243-54. PubMed ID: 23492607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery stents: evaluating new designs for contemporary percutaneous intervention.
    Kandzari DE; Tcheng JE; Zidar JP
    Catheter Cardiovasc Interv; 2002 Aug; 56(4):562-76. PubMed ID: 12124974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.